Baird Medical Investment Holdings (BDMDW) Common Equity (2023 - 2025)

Baird Medical Investment Holdings has reported Common Equity for 3 years, with the latest figure at $31.2 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 21.47% year-over-year to $31.2 million; the trailing twelve-month figure through Dec 2025 stood at $31.2 million (down 21.47% YoY), and the FY2025 full-year result was $31.2 million, down 21.47% from the prior year.
• Common Equity for Q4 2025 stood at $31.2 million, down from $35.6 million in the prior quarter.
• The five-year high for Common Equity was $39.8 million in Q4 2024, with the low at $31.2 million in Q4 2025.
• Average Common Equity over 3 years is $35.6 million, with a median of $35.7 million recorded in 2023.
• Year-over-year, Common Equity advanced 11.35% in 2024 and declined 21.47% in 2025.
• Tracing BDMDW's Common Equity over 3 years: stood at $35.7 million in 2023, then climbed by 11.35% to $39.8 million in 2024, then fell by 21.47% to $31.2 million in 2025.
• The last three Common Equity figures came in at $31.2 million (Q4 2025), $35.6 million (Q2 2025), and $39.8 million (Q4 2024), per Business Quant data.

Peer Comparison